AcquisitionVimian announced the acquisition of AllAccem Inc., a US-based company focused on veterinary dental care, with an EBITDA margin well above group average.
Growth StrategyThe acquisition aligns with the company's goal to broaden its MedTech portfolio with high-growth, high-margin businesses operating in specialized segments of animal health.
Stock Market ListingThe Listing Committee of Nasdaq Stockholm approved Vimian's application to be listed on the Nasdaq Stockholm Main Market in the Large Cap segment.